Jillian Godfrey Scaife Discusses Biosimilar Interchangeability Guidance with Specialty Pharmacy Times

 

Principal Jillian Godfrey Scaife recently spoke with Specialty Pharmacy Times about the impact that the FDA’s recent biosimilar interchangeability draft guidance will have on specialty pharmacy.

Read the Q&A here: http://bit.ly/2jZdudr

See all Thought Leadership posts